FOX News logo
Boston Herald logo
CBS News logo
4 articles
·1M

FDA Approves First Blood Test for Alzheimer’s Diagnosis

The FDA has approved a blood test to help diagnose Alzheimer’s in patients over 55, marking a milestone in cognitive health.


Overview

A summary of the key points of this story verified across multiple sources.

The FDA has endorsed the Lumipulse blood test from Fujirebio Diagnostics, Inc. for diagnosing Alzheimer’s disease in individuals over 55 with cognitive decline. This first-ever blood test identifies beta-amyloid plaques linked to Alzheimer’s, offering a less invasive and more cost-effective alternative to costly PET scans and spinal fluid tests. This approval supports early intervention with new treatments like Leqembi and Kisunla, which can modestly slow disease progression. Dr. Michelle Tarver from the FDA emphasized the test’s potential for improving patient access to timely diagnosis and appropriate treatment.

Content generated by AI—learn more or report issue.

Pano Newsletter

Get both sides in 5 minutes with our daily newsletter.

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

There are not enough sources from this perspective to provide an analysis.

Articles (4)

Compare how different news outlets are covering this story.

LeftCenterRight
CBS News
Associated Press
Boston Herald
FOX News

FAQ

A list of follow-up questions readers often ask about this story.